Pharmaceutical Preparations · DE · CIK 1082554
Develops and sells therapies for serious diseases and innovative organ manufacturing technologies
Comparable business profile · signals at a glance
Coverage (30d): 1 reputable article · skews ▲ positive.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
In the 90 days to Mar 30, 2026: 9 sold $236.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,790 | $588.33 | $1.1M |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,734 | $589.18 | $1.0M |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,487 | $588.42 | $875K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,346 | $587.34 | $791K |
| Mar 30, 2026 | Causey ChristopherDirector | Sell | 1,300 | $604.64 | $786K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,196 | $589.23 | $705K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 1,068 | $590.32 | $630K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 1,026 | $590.36 | $606K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 860 | $587.35 | $505K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 790 | $599.82 | $474K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 770 | $604.64 | $466K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 602 | $591.24 | $356K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 500 | $595.91 | $298K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 480 | $594.74 | $285K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 481 | $591.26 | $284K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 437 | $586.27 | $256K |
| Mar 30, 2026 | Edgemond JamesCFO AND TREASURER | Sell | 417 | $602.53 | $251K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 400 | $594.61 | $238K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 354 | $586.07 | $207K |
| Mar 30, 2026 | Rothblatt Martine AChairperson & CEO | Sell | 320 | $595.80 | $191K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.